Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of August 13, 2025 • 2:11 PM ET

Date/Time Source News Release
07/30/2025 07:25 AM EDT GlobeNewswire Appendix 4C - Q4 FY25 Quarterly Cash Flow Report
07/28/2025 07:25 AM EDT GlobeNewswire Alterity Therapeutics Reports Positive Topline Data from Open-Label Phase 2 Clinical Trial of ATH434 in Multiple System Atrophy
07/24/2025 07:25 AM EDT GlobeNewswire Alterity Therapeutics Announces Publication on Novel MRI Endpoint from the bioMUSE Natural History Study
06/23/2025 07:25 AM EDT GlobeNewswire Alterity Therapeutics to Provide Corporate Update in Fireside Chat
05/12/2025 07:35 AM EDT GlobeNewswire Alterity Therapeutics Prominently Featured at the International MSA Congress
05/07/2025 08:16 AM EDT GlobeNewswire Alterity Therapeutics Announces Multiple Oral and Poster Presentations to be Featured at the International MSA Congress
05/05/2025 07:35 AM EDT GlobeNewswire Alterity Therapeutics Granted U.S. FDA Fast Track Designation for ATH434 to Treat Multiple System Atrophy
04/30/2025 07:35 AM EDT GlobeNewswire Appendix 4C - Q3 FY25 Quarterly Cash Flow Report
04/28/2025 07:35 AM EDT GlobeNewswire Alterity Therapeutics Presents ATH434-201 Phase 2 Clinical Trial Results at European MSA Symposium
04/10/2025 07:35 AM EDT GlobeNewswire Alterity Therapeutics Presents Encouraging New Data from its ATH434 Phase 2 Trial in Multiple System Atrophy at the American Academy of Neurology Annual Meeting
Page

Additional News

As of August 13, 2025 • 2:11 PM ET

Date/Time Source News Release
08/03/2025 06:45 PM EDT KlickAnalytics ATHE - Historical Price Movements Surrounding Earnings
08/03/2025 06:40 PM EDT KlickAnalytics ATHE - Historical Earnings Price Analysis
07/28/2025 10:33 AM EDT SeekingAlpha Alterity reports data from multiple system atrophy study
07/28/2025 10:00 AM EDT QM US Market Movers News US Companies Moving the Markets, Morning edition
Mon, Jul 28, 2025 as of 10.00 am ET
05/05/2025 02:00 PM EDT PRISM News PRISM Mid-Day Movers: Trial Results and FDA Fast Tracks Drive Indices Higher
02/10/2025 08:54 AM EST SeekingAlpha Alterity Therapeutics raises A$40 million
01/30/2025 09:47 AM EST Baystreet Alterity Vaults on Drug Test Results
01/30/2025 08:36 AM EST 24/7 Market News Alterity Therapeutics Reports Positive ATH434 Phase 2 Trial Results in MSA
09/30/2024 08:00 AM EDT SeekingAlpha Alterity Therapeutics appoints Abby Macnish Niven as CFO
08/25/2024 08:01 AM EDT SeekingAlpha Earnings week ahead: NVIDIA, CrowdStrike, Salesforce, Lululemon and more
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.